RFK Jr.'s Vaccine Panel Endorses Merck's RSV Shot for Infants
TL;DR Summary
RFK Jr’s vaccine advisory panel recommended the new monoclonal antibody treatment, clesrovimab, for infants to prevent RSV, despite controversy over panel composition and vaccine ingredients; the treatment aims to protect the most vulnerable infants during RSV season, with evidence showing it reduces hospitalizations.
- RFK Jr’s vaccine panel recommends new RSV treatment for infants The Guardian
- CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies ABC News - Breaking News, Latest News and Videos
- In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants USA Today
- RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants CNBC
- CDC vaccine advisers recommend Merck’s RSV therapy for babies STAT
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
94%
678 → 43 words
Want the full story? Read the original article
Read on The Guardian